A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2009
End Date:November 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Pharmacodynamics Of CP-690,550, Administered Orally Twice Daily (BID) For 4 Weeks, In Subjects With Active Rheumatoid Arthritis


To explore the effect of CP-690,550 on blood and synovial markers in subjects with
rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.



We found this trial at
7
sites
Pfizer Investigational Site
Akron, Ohio 44314
?
mi
from
Akron, OH
Click here to add this to my saved trials
Pfizer Investigational Site
Alabaster, Alabama 35007
?
mi
from
Alabaster, AL
Click here to add this to my saved trials
Maine Research Associates
Auburn, Maine 04210
?
mi
from
Auburn, ME
Click here to add this to my saved trials
Pfizer Investigational Site
Baltimore, Maryland 21234
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pfizer Investigational Site
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Pfizer Investigational Site
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pfizer Investigational Site
Seattle, Washington 98166
?
mi
from
Seattle, WA
Click here to add this to my saved trials